OCRH
Side effects
Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels |
|---|---|---|---|
| 1 | |||
| Dyspnoea | x | ||
| Endocrine disorder | x | ||
| Epilepsy | x | ||
| Flushing | x | ||
| Cardiac arrest | x | ||
| Hypotension | x | ||
| Tachycardia | x | ||
| Loss of consciousness | x | ||
| Drug interaction | x | ||
| Secondary adrenal insufficiency | x | ||
| Respiratory depth increased | x | ||
Indications
Information about indications was extracted from the indications and usage sections of the labels.
Color scheme:
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |
